| Sole Remedy Llc | |
| 651 Orchard Street, Suite 202a, New Bedford, Massachusetts 02744 | |
| (508) 295-8800 |
| Name | Sole Remedy Llc |
|---|---|
| Organization Name | Sole Remedy Llc |
| Location | 651 Orchard Street, Suite 202a, New Bedford, Massachusetts 02744 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (508) 295-8800 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration has approved a Humanitarian Use Device (HUD) designation for the SynCardia temporary Total Artificial Heart to be used for destination therapy in addition to its current PMA approval as a bridge to transplant.
Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.
Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).
The coronavirus disease (COVID-19) outbreak has taken a toll on the lives of many people, especially in mainland China. However, over the past week, the virus has spread to more than 40 countries, infecting over 83,000 people with more than 2,800 deaths. Now, the UK's case toll increased to 16 as Northern Ireland reported its first coronavirus case.
Cell Biosciences, Inc. and Alpha Innotech Corp. today announced that they have entered into a definitive agreement providing for the acquisition of Alpha Innotech by Cell Biosciences for $1.50 per share, or approximately $17.9 million in cash.
› Verified 7 days ago
| NPI Number | 1114250552 |
| Organization Name | SOLE REMEDY LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 651 Orchard St, Suite 202a, New Bedford, MA 02744 |
| Phone Number | 508-295-8800 |
News Archive
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration has approved a Humanitarian Use Device (HUD) designation for the SynCardia temporary Total Artificial Heart to be used for destination therapy in addition to its current PMA approval as a bridge to transplant.
Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.
Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).
The coronavirus disease (COVID-19) outbreak has taken a toll on the lives of many people, especially in mainland China. However, over the past week, the virus has spread to more than 40 countries, infecting over 83,000 people with more than 2,800 deaths. Now, the UK's case toll increased to 16 as Northern Ireland reported its first coronavirus case.
Cell Biosciences, Inc. and Alpha Innotech Corp. today announced that they have entered into a definitive agreement providing for the acquisition of Alpha Innotech by Cell Biosciences for $1.50 per share, or approximately $17.9 million in cash.
› Verified 7 days ago
News Archive
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration has approved a Humanitarian Use Device (HUD) designation for the SynCardia temporary Total Artificial Heart to be used for destination therapy in addition to its current PMA approval as a bridge to transplant.
Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.
Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).
The coronavirus disease (COVID-19) outbreak has taken a toll on the lives of many people, especially in mainland China. However, over the past week, the virus has spread to more than 40 countries, infecting over 83,000 people with more than 2,800 deaths. Now, the UK's case toll increased to 16 as Northern Ireland reported its first coronavirus case.
Cell Biosciences, Inc. and Alpha Innotech Corp. today announced that they have entered into a definitive agreement providing for the acquisition of Alpha Innotech by Cell Biosciences for $1.50 per share, or approximately $17.9 million in cash.
› Verified 7 days ago
American Diagnostic Lab Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 92 Grape St, New Bedford, Massachusetts 02740 Phone: (800) 233-9996 | |
Cvs Pharmacy # 00492 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2100 Acushnet Avenue, New Bedford, Massachusetts 02745 Phone: (508) 995-2653 | |
Cvs Pharmacy # 00685 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1145 Kempton Street, New Bedford, Massachusetts 02740 Phone: (508) 999-3241 | |
Cvs Pharmacy #00789 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 136 Ashley Blvd, New Bedford, Massachusetts 02746 Phone: (508) 996-2094 | |
Cvs Pharmacy #00799 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 786 Ashley Blvd, New Bedford, Massachusetts 02745 Phone: (508) 998-3831 |